Glenmark’s Ryaltris nasal spray now approved in Europe for the first line treatment of allergic rhinitis in patients over 12 years of age
#Glenmark
#RyaltrisNasalSpray
Glenmark’s Ryaltris nasal spray now approved in Europe for the first line treatment of allergic rhinitis in patients over 12 years of age
Glenmark
#Glenmark
#RyaltrisNasalSpray
Glenmark Pharmaceuticals and Menarini enter into exclusive licensing agreement for commercializing Ryaltris Nasal Spray
#GlenmarkPharmaceuticals #Menarini #licensingagreement #RyaltrisNasalSpray
wp.me/pcjAAj-32a